Screened 2026-08-26 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its distribution label.
Tenable Holdings, Inc. holds its Distribution at $33.66. The statistical read favours the buyers, held for 66 days.
As held on the ledger · 2026-08-26
Phase
Distribution · caution
Quantitative state
The statistical read favours the buyers, held for 66 days
Price at the screen
$33.66
Valuation
561.00 trailing · 15.41 forward price to earnings
Values screen
PASS· score 70.0
Beta
0.94
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
23.73%
Below 33%
Interest-bearing debt is just 23.7% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
12.27%
Below 33%
Cash held in interest-bearing accounts and securities is 12.3% of assets, under the one-third limit.
Pass
Receivables
26.72%
Below 49%
Money owed to the company is 26.7% of assets, under the 49% limit.
Pass
Revenue purity
1.60%
Below 5%
Only 1.6% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-08-26 screen. The gold marker is the market price at the same screen. A 30.0% margin of safety to the base estimate.
Third-party analyst targets: 20 covering, consensus None. The average target sits +4% from the screen price.
Reading the gap · Our model sees value the Street hasn't fully caught up to yet.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-26 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Cybersecurity tool priced well beyond its worth
Picture a firm selling digital armour that promises to spot every crack in your defences. Tenable sells exactly that, yet the market values it as if profits were already flowing strongly and growth accelerating fast. We pass because the current price sits 22% above our fair value with revenue expanding just 10% and both profit margins and returns on equity still negative.
The forward multiple of 18.4 times earnings looks ordinary until you notice the business has yet to turn a profit. Analysts may cluster around a buy rating with a $30 median target, yet that sits below today's quote and leaves little margin for the execution risks that come with an unknown competitive moat. Ethical screens clear, but the numbers do not support ownership here.
High expectations baked into the share price leave little room for slower adoption or tougher competition in exposure management. A single quarter of missed growth could reset sentiment quickly. Analysis, not advice.
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
TENB trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-14Markup$36.38+35.7%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 35.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (20 analysts) rates it buy, with a mean price target of $29.
2026-07-18Markup$26.80+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (20 analysts) rates it buy, with a mean price target of $29.
2026-07-03Markup$26.80+0.0%Entry 2
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Markup$26.80Entry 1
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
